International Clinical Trial: fNIRS as a biomarker for individuals with subjective cognitive decline and MCI

Geneva, May 29 -- International Clinical Trials Registry received information related to the study (ChiCTR2600124936) titled 'fNIRS as a biomarker for individuals with subjective cognitive decline and MCI' on May 19.

Study Type: Observational study

Study Design: Factorial

Primary Sponsor: The First Affiliated Hospital of Xiamen University

Condition: Mild Cognitive Impairment

Intervention: Mild Cognitive Impairment group:No Healthy control group:No

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-05-20

Target Sample Size: Mild Cognitive Impairment group:24;Healthy control group:24;Subjective Cognitive Decline group:24;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.c...